Here we demonstrate that, by combining a minimal-intensity immunoablative conditioning regimen with a high stem-cell and T-cell dose graft, XIAP deficiency with uncontrolled HLH can be cured, even in the presence of other independent poor prognostic factors. Although anti-CD45 monoclonal antibodies...